JP2024534801A5 - - Google Patents
Info
- Publication number
- JP2024534801A5 JP2024534801A5 JP2024510239A JP2024510239A JP2024534801A5 JP 2024534801 A5 JP2024534801 A5 JP 2024534801A5 JP 2024510239 A JP2024510239 A JP 2024510239A JP 2024510239 A JP2024510239 A JP 2024510239A JP 2024534801 A5 JP2024534801 A5 JP 2024534801A5
- Authority
- JP
- Japan
- Prior art keywords
- heterocyclylalkyl
- alkyl
- heteroaryl
- aryl
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163235543P | 2021-08-20 | 2021-08-20 | |
| US63/235,543 | 2021-08-20 | ||
| US202163289025P | 2021-12-13 | 2021-12-13 | |
| US63/289,025 | 2021-12-13 | ||
| PCT/US2022/040922 WO2023023347A1 (en) | 2021-08-20 | 2022-08-19 | Prodrugs and derivatives of psilocin and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534801A JP2024534801A (ja) | 2024-09-26 |
| JP2024534801A5 true JP2024534801A5 (enExample) | 2025-08-25 |
Family
ID=85241100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024510239A Pending JP2024534801A (ja) | 2021-08-20 | 2022-08-19 | サイロシンのプロドラッグ及び誘導体ならびにその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250011344A1 (enExample) |
| EP (1) | EP4387608A4 (enExample) |
| JP (1) | JP2024534801A (enExample) |
| KR (1) | KR20240065084A (enExample) |
| AU (1) | AU2022328556A1 (enExample) |
| CA (1) | CA3229591A1 (enExample) |
| TW (1) | TW202315863A (enExample) |
| WO (1) | WO2023023347A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3188636A1 (en) * | 2020-08-21 | 2022-02-24 | Matthias GRILL | Novel psilocin derivatives having prodrug properties |
| EP4255422A4 (en) * | 2020-12-03 | 2024-12-18 | Mydecine Innovations Group Inc. | NEW PSILOCIN ANALOGUE COMPOSITIONS AND METHODS OF THEIR SYNTHESIS |
| AU2022309017A1 (en) | 2021-07-07 | 2024-01-25 | Terran Biosciences Inc. | N,n-dimethyltryptamine and related psychedlics and uses thereof |
| US20250011351A1 (en) | 2021-11-12 | 2025-01-09 | Terran Biosciences Inc. | Psilocybin and o-acetylpsilocin, salts and solid state forms thereof |
| IL313455A (en) | 2021-12-15 | 2024-08-01 | Delix Therapeutics Inc | Phenoxy and benzyloxy modified psychroplastogens and their uses |
| WO2023168023A1 (en) | 2022-03-04 | 2023-09-07 | Reset Pharmaceuticals, Inc. | Co-crystals or salts comprising psilocin |
| WO2023173196A1 (en) | 2022-03-18 | 2023-09-21 | Enveric Biosciences Canada Inc. | C4-carboxylic acid-substituted tryptamine derivatives and methods of using |
| CA3246245A1 (en) * | 2022-03-18 | 2023-09-21 | Enveric Biosciences Canada Inc. | C4 CARBOXYLIC ACID SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USE |
| AU2023234202A1 (en) * | 2022-03-18 | 2024-11-07 | Enveric Biosciences Canada Inc. | Salts of c4-carboxylic acid- and c4-carbonothioate-substituted tryptamine derivatives and methods of using |
| US20260085040A1 (en) * | 2022-09-12 | 2026-03-26 | Bionxt Solutions Inc. | Amino acid and carbohydrate psilocin derivatives |
| WO2024108195A1 (en) | 2022-11-17 | 2024-05-23 | Remedi, Inc. | Combinations of monoamine oxidase inhibitors and serotonin receptor agonists and their therapeutic use |
| US20240269113A1 (en) * | 2023-01-24 | 2024-08-15 | Compass Pathfinder Limited | 3-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-4-yl DERIVATIVES |
| TW202525777A (zh) * | 2023-08-25 | 2025-07-01 | 英商康派斯開拓者公司 | ３－（２－（二甲基胺基）乙基）－１ｈ－吲哚－４－基衍生物 |
| EP4592276A1 (en) | 2024-01-29 | 2025-07-30 | Universität Heidelberg | Novel acyloxymethyl prodrugs of psilocin and related 4-hydroxytryptamines obtained by an efficient synthetic approach |
| CN120329323B (zh) * | 2025-04-16 | 2026-01-13 | 黄冈鲁班药业股份有限公司 | 一种头孢吡普酯侧链的制备方法及应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3075992A (en) * | 1958-09-12 | 1963-01-29 | Sandoz Ltd | Esters of indoles |
| US20180021326A1 (en) * | 2016-07-23 | 2018-01-25 | Paul Edward Stamets | Compositions and methods for enhancing neuroregeneration and cognition by combining mushroom extracts containing active ingredients psilocin or psilocybin with erinacines or hericenones enhanced with niacin |
| US20190142851A1 (en) * | 2017-11-16 | 2019-05-16 | CaaMTech, LLC | Compositions comprising a psilocybin derivative and a cannabinoid |
| KR20220137081A (ko) * | 2020-02-04 | 2022-10-11 | 마인드셋 파마 인크. | Cns 장애의 치료를 위한 세로토닌성 사이키델릭 작용제로서의 실로신 유도체 |
| WO2021226416A1 (en) * | 2020-05-08 | 2021-11-11 | Psilera Inc. | Novel compositions of matter and pharmaceutical compositions |
| CN119285527A (zh) * | 2020-06-30 | 2025-01-10 | 瑞安神经科学公司 | 色胺前药 |
| CA3188636A1 (en) * | 2020-08-21 | 2022-02-24 | Matthias GRILL | Novel psilocin derivatives having prodrug properties |
| EP4255422A4 (en) * | 2020-12-03 | 2024-12-18 | Mydecine Innovations Group Inc. | NEW PSILOCIN ANALOGUE COMPOSITIONS AND METHODS OF THEIR SYNTHESIS |
| AU2022287974A1 (en) * | 2021-06-09 | 2024-01-04 | Atai Therapeutics, Inc. | Novel prodrugs and conjugates of dimethyltryptamine |
-
2022
- 2022-08-19 JP JP2024510239A patent/JP2024534801A/ja active Pending
- 2022-08-19 KR KR1020247008856A patent/KR20240065084A/ko active Pending
- 2022-08-19 AU AU2022328556A patent/AU2022328556A1/en active Pending
- 2022-08-19 CA CA3229591A patent/CA3229591A1/en active Pending
- 2022-08-19 EP EP22859231.7A patent/EP4387608A4/en active Pending
- 2022-08-19 TW TW111131397A patent/TW202315863A/zh unknown
- 2022-08-19 US US18/684,970 patent/US20250011344A1/en not_active Abandoned
- 2022-08-19 WO PCT/US2022/040922 patent/WO2023023347A1/en not_active Ceased